Inventor · disambiguated record
Kei Roger Aoki
Also filed as: AOKI KEI · AOKI KEI R · AOKI KEI ROGER
162 granted patents·61 pending applications·4,703 citations·filing 1986–2022
99Inventor score
Files withALLERGAN INC113NIPPON PAINT CO LTD34STEWARD LANCE E14ALLERGAN SALES INC10FERNANDEZ-SALAS ESTER10
Top patents by PatentIndex Score
223 records- 0199US7897157B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Mar 1, 2011·62 cites·29 claims
- 0299US7749514B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Jul 6, 2010·64 cites·19 claims
- 0399US6113915AMethods for treating painALLERGAN SALES INC·Filed 1999·Granted Sep 5, 2000·295 cites·36 claims
- 0498US11332518B2Immuno-based botulinum toxin serotype A activity assaysALLERGAN INC·Filed 2021·Granted May 17, 2022·7 cites·30 claims
- 0598US7811584B2Multivalent clostridial toxinsALLERGAN INC·Filed 2008·Granted Oct 12, 2010·79 cites·12 claims
- 0698US7740868B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Jun 22, 2010·63 cites·34 claims
- 0798US7718766B2Fret protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2008·Granted May 18, 2010·37 cites·19 claims
- 0898US7709608B2Substrates useful for FRET protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2006·Granted May 4, 2010·37 cites·33 claims
- 0998US7659092B2Fusion proteinsSYNTAXIN LTD·Filed 2007·Granted Feb 9, 2010·58 cites·5 claims
- 1098US7645570B2Botulinum toxin screening assaysALLERGAN INC·Filed 2008·Granted Jan 12, 2010·68 cites·20 claims
- 1198US7598027B2Botulinum toxin screening assaysALLERGAN INC·Filed 2005·Granted Oct 6, 2009·61 cites·29 claims
- 1298US7495069B2FRET protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2006·Granted Feb 24, 2009·52 cites·30 claims
- 1398US7332567B2Fret protease assays for clostridial toxinsALLERGAN INC·Filed 2001·Granted Feb 19, 2008·96 cites·131 claims
- 1498US7208285B2Fret protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2001·Granted Apr 24, 2007·117 cites·88 claims
- 1598US7183066B2Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxinsALLERGAN INC·Filed 2002·Granted Feb 27, 2007·126 cites·39 claims
- 1698US6843998B1Methods and compositions for the treatment of pancreatitisALLERGAN INC·Filed 2000·Granted Jan 18, 2005·134 cites·10 claims
- 1798US6787517B1Agent and methods for treating painALLERGAN INC·Filed 2000·Granted Sep 7, 2004·134 cites·46 claims
- 1898US6423319B1Methods for treating muscle injuriesALLERGAN SALES INC·Filed 2000·Granted Jul 23, 2002·226 cites·11 claims
- 1997US11261240B2Immuno-based botulinum toxin serotype A activity assaysALLERGAN INC·Filed 2020·Granted Mar 1, 2022·7 cites·16 claims
- 2097US8198034B2Immuno-based botulinum toxin serotype A activity assaysFERNANDEZ-SALAS ESTER·Filed 2009·Granted Jun 12, 2012·63 cites·25 claims
- 2197US8071110B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Dec 6, 2011·32 cites·13 claims
- 2297US7846722B2Luminescence resonance energy transfer (LRET) assays for clostridial toxin activityALLERGAN INC·Filed 2007·Granted Dec 7, 2010·55 cites·18 claims
- 2397US7749759B2Cell compositions useful for cell-based FRET assays for clostridial toxinsALLERGAN INC·Filed 2008·Granted Jul 6, 2010·39 cites·61 claims
- 2497US7678550B1FRET protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2006·Granted Mar 16, 2010·35 cites·41 claims
- 2597US7674601B2Fluorescence polarization assays for determining clostridial toxin activityALLERGAN INC·Filed 2008·Granted Mar 9, 2010·34 cites·28 claims
- 2697US7658933B2Non-cytotoxic protein conjugatesSYNTAXIN LTD·Filed 2007·Granted Feb 9, 2010·57 cites·4 claims
- 2797US7514088B2Multivalent Clostridial toxin derivatives and methods of their useALLERGAN INC·Filed 2006·Granted Apr 7, 2009·106 cites·27 claims
- 2897US6869610B2Pain treatment by peripheral administration of a neurotoxinALLERGAN SALES INC·Filed 2002·Granted Mar 22, 2005·89 cites·7 claims
- 2997US6464986B1Method for treating pain by peripheral administration of a neurotoxinALLEGAN SALES INC·Filed 2000·Granted Oct 15, 2002·267 cites·13 claims
- 3096US8124357B2Lipophilic dye-based fret assays for clostridal toxin activityFERNANDEZ-SALAS ESTER·Filed 2006·Granted Feb 28, 2012·36 cites·17 claims
- 3196US8067200B2Fusion proteinsFOSTER KEITH·Filed 2005·Granted Nov 29, 2011·43 cites·35 claims
- 3296US7838260B2GFP-SNAP25 fluorescence release assay for botulinum toxin protease activityALLERGAN INC·Filed 2008·Granted Nov 23, 2010·22 cites·26 claims
- 3396US7638294B2Fluorescence polarization assays for determining clostridial toxin activityALLERGAN INC·Filed 2008·Granted Dec 29, 2009·30 cites·27 claims
- 3496US7635574B2Fluorescence polarization assays for determining clostridial toxin activityALLERGAN INC·Filed 2008·Granted Dec 22, 2009·28 cites·27 claims
- 3596US7632655B2Fluorescence polarization assays for determining clostridial toxin activityALLERGAN INC·Filed 2008·Granted Dec 15, 2009·28 cites·28 claims
- 3696US7456272B2Neurotoxins with enhanced target specificityALLERGAN INC·Filed 2007·Granted Nov 25, 2008·27 cites·20 claims
- 3796US7399607B2Fluorescence polarization assays for determining clostridial toxin activityALLERGAN INC·Filed 2004·Granted Jul 15, 2008·78 cites·36 claims
- 3896US7393925B2Leucine-based motif and Clostridial neurotoxinsALLERGAN INC·Filed 2005·Granted Jul 1, 2008·24 cites·2 claims
- 3995US8623999B2Modified Clostridial toxins with enhanced targeting capabilities for endogenous Clostridial toxin receptor systemsSTEWARD LANCE E·Filed 2012·Granted Jan 7, 2014·27 cites·3 claims
- 4095US8603779B2Non-cytotoxic protein conjugatesFOSTER KEITH·Filed 2012·Granted Dec 10, 2013·23 cites·15 claims
- 4195US8187834B2Non-cytotoxic protein conjugatesFOSTER KEITH·Filed 2005·Granted May 29, 2012·33 cites·12 claims
- 4295US8052979B2Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cellsALLERGAN INC·Filed 2006·Granted Nov 8, 2011·30 cites·16 claims
- 4395US6903187B1Leucine-based motif and clostridial neurotoxinsALLERGAN INC·Filed 2000·Granted Jun 7, 2005·42 cites·7 claims
- 4494US9249216B2Immuno-based botulinum toxin serotype A activity assaysFERNANDEZ-SALAS ESTER·Filed 2012·Granted Feb 2, 2016·23 cites·4 claims
- 4594US8618261B2Immuno-based botulinum toxin serotype A activity assaysESTER FERNANDEZ-SALAS·Filed 2010·Granted Dec 31, 2013·44 cites·2 claims
- 4694US8128940B2Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systemsSTEWARD LANCE E·Filed 2006·Granted Mar 6, 2012·25 cites·5 claims
- 4794US7993656B2Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cellsALLERGAN INC·Filed 2007·Granted Aug 9, 2011·22 cites·5 claims
- 4894US7641833B2Method for producing a pellet from a fiber-filled resin composition and injection-molded products thereofPOLYPLASTICS CO·Filed 2005·Granted Jan 5, 2010·25 cites·7 claims
- 4994US7276473B2Methods and compositions for the treatment of pancreatitisALLERGAN INC·Filed 2004·Granted Oct 2, 2007·30 cites·18 claims
- 5094US7273722B2Neurotoxins with enhanced target specificityALLERGAN INC·Filed 2000·Granted Sep 25, 2007·39 cites·62 claims
Showing the top 50 of 223 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →